Navigating Innovation and Regulation in Cell and Gene Therapy

Join this insightful dialogue where we’ll explore advancements in the evolving world of cell and gene therapy analysis with Daniel Galbraith, Chief Scientific Officer of Solvias. Daniel shares insights from the forefront of drug development, including the complexities of development and commercialization, the financial dynamics of new therapies and changing regulatory landscapes. This podcast provides an enlightening conversation about the dynamic cell and gene therapy analysis space and provides a unique look at the innovations driving the industry forward.

Download Q&A

Related Content

Advertisement

August 4th 2025

Handling Sterile Potent, Powders Inside a Single Use, Disposable Aseptic Isolator with Martyn Ryder

ILC Dover

During this podcast we shall be discussing how sterile potent powders are becoming more common in the bio-pharmaceutical industry and the challenges around handling these powders in conventional aseptic containment systems. Review the overarching benefits of compliant. single use isolator systems when handling sterile products and how they mitigate the risk associated with potent product batch manufacture.

August 4th 2025

Transformations in Drug Development for Cell and Gene Therapies

PPD Thermo Fisher Scientific

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

August 4th 2025

Accelerating Timeline by Planning for Clinical Supplies in Advance

Catalent

August 4th 2025

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD Thermo Fisher Scientific

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

August 4th 2025

Discover Lonza Engine

Capsugel® Ι Lonza Pharma & Biotech

August 4th 2025

A Patient-Centric Solution

Adare Pharmaceuticals

Related Content

Advertisement

August 4th 2025

Handling Sterile Potent, Powders Inside a Single Use, Disposable Aseptic Isolator with Martyn Ryder

ILC Dover

During this podcast we shall be discussing how sterile potent powders are becoming more common in the bio-pharmaceutical industry and the challenges around handling these powders in conventional aseptic containment systems. Review the overarching benefits of compliant. single use isolator systems when handling sterile products and how they mitigate the risk associated with potent product batch manufacture.

August 4th 2025

Transformations in Drug Development for Cell and Gene Therapies

PPD Thermo Fisher Scientific

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

August 4th 2025

Accelerating Timeline by Planning for Clinical Supplies in Advance

Catalent

August 4th 2025

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD Thermo Fisher Scientific

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

August 4th 2025

Discover Lonza Engine

Capsugel® Ι Lonza Pharma & Biotech

August 4th 2025

A Patient-Centric Solution

Adare Pharmaceuticals